XML 25 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Equity - USD ($)
shares in Millions, $ in Millions
Total
Shares of Common Stock
Common Stock and Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Beginning balance (in shares) at Jul. 27, 2019   4,250          
Balance, beginning of period at Jul. 27, 2019 $ 33,571   $ 40,266 $ (5,903) $ (792)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 11,214     11,214      
Other comprehensive income (loss) 273       273    
Issuance of common stock (in shares)   61          
Issuance of common stock $ 655   655        
Repurchase of common stock (in shares) (59) (59)          
Repurchase of common stock $ (2,619)   (561) (2,058)      
Shares repurchased for tax withholdings on vesting of restricted stock units (in shares)   (15)          
Shares repurchased for tax withholdings on vesting of restricted stock units (727)   (727)        
Cash dividends declared (6,016)     (6,016)      
Share-based compensation 1,569   1,569        
Ending balance (in shares) at Jul. 25, 2020   4,237          
Balance, end of period at Jul. 25, 2020 37,920   41,202 (2,763) (519) $ (38) $ (38)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 10,591     10,591      
Other comprehensive income (loss) 102       102    
Issuance of common stock (in shares)   58          
Issuance of common stock $ 643   643        
Repurchase of common stock (in shares) (64) (64)          
Repurchase of common stock $ (2,902)   (625) (2,277)      
Shares repurchased for tax withholdings on vesting of restricted stock units (in shares)   (14)          
Shares repurchased for tax withholdings on vesting of restricted stock units (636)   (636)        
Cash dividends declared (6,166)     (6,166)      
Share-based compensation 1,761   1,761        
Other 0   1 (1)      
Ending balance (in shares) at Jul. 31, 2021   4,217          
Balance, end of period at Jul. 31, 2021 41,275   42,346 (654) (417)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 11,812     11,812      
Other comprehensive income (loss) (1,205)       (1,205)    
Issuance of common stock (in shares)   54          
Issuance of common stock $ 660   660        
Repurchase of common stock (in shares) (146) (146)          
Repurchase of common stock $ (7,734)   (1,490) (6,244)      
Shares repurchased for tax withholdings on vesting of restricted stock units (in shares)   (13)          
Shares repurchased for tax withholdings on vesting of restricted stock units (692)   (692)        
Cash dividends declared (6,224)     (6,224)      
Share-based compensation 1,886   1,886        
Other (in shares)   (2)          
Other (5)   4 (9)      
Ending balance (in shares) at Jul. 30, 2022   4,110          
Balance, end of period at Jul. 30, 2022 $ 39,773   $ 42,714 $ (1,319) $ (1,622)